| ALX-803-320-C100 | 100 µg | 510.00 USD |  |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | Acute myeloid leukemia 2 protein, Runt-related transcription factor 3, CBF-α3, AML-2, Core-binding factor α3 subunit |
| Clone: | R3-1E10 |
| Host: | Mouse |
| Isotype: | IgG1 |
| Immunogen: | Recombinant human RUNX3 (runt-related transcription factor 3) (aa 191-300). |
| UniProt ID: | Q13761 |
| Species reactivity: | Human, Mouse |
| Applications: | IHC, WB |
| Recommended Dilutions/Conditions: | Immunohistochemistry (paraffin sections, 2µg/ml) Western Blot (0.2µg/ml) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
| Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
| Handling: | Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C. |
| Shipping: | Blue Ice |
| Short Term Storage: | +4°C |
| Long Term Storage: | -20°C |
| Scientific Background: | RUNX (Runt-related transcription factor) family members play important roles in normal developmental processes and carcinogenesis. Of the three known RUNX family members, the ubiquitously expressed RUNX3 is involved in neurogenesis, T cell differentiation, tumorigenesis and is a component of the TGF-β induced tumor suppressor pathway. In gastric cancer cells, RUNX3 induces cell cycle arrest and apoptosis through upregulation of Bim, a proapoptotic BH3-only protein. In addition, RUNX3 is frequently inactivated in gastric cancer cells. |
| Regulatory Status: | RUO - Research Use Only |
